RetractedArticleScientific reports2021

Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis.

Rui Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.